DK0552240T3 - Ny metode til behandling af depression - Google Patents
Ny metode til behandling af depressionInfo
- Publication number
- DK0552240T3 DK0552240T3 DK91918381T DK91918381T DK0552240T3 DK 0552240 T3 DK0552240 T3 DK 0552240T3 DK 91918381 T DK91918381 T DK 91918381T DK 91918381 T DK91918381 T DK 91918381T DK 0552240 T3 DK0552240 T3 DK 0552240T3
- Authority
- DK
- Denmark
- Prior art keywords
- new method
- treating depression
- depression
- treating
- compounds
- Prior art date
Links
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 abstract 2
- -1 cyclic amino acids Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960002870 gabapentin Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/596,270 US5025035A (en) | 1990-10-12 | 1990-10-12 | Method of treating depression |
| PCT/US1991/007330 WO1992006686A1 (fr) | 1990-10-12 | 1991-10-02 | Nouveau procede de traitement de la depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0552240T3 true DK0552240T3 (da) | 1998-11-23 |
Family
ID=24386662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK91918381T DK0552240T3 (da) | 1990-10-12 | 1991-10-02 | Ny metode til behandling af depression |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5025035A (fr) |
| EP (1) | EP0552240B1 (fr) |
| JP (1) | JP3192141B2 (fr) |
| AT (1) | ATE164065T1 (fr) |
| CA (1) | CA2092416A1 (fr) |
| DE (1) | DE69129115T2 (fr) |
| DK (1) | DK0552240T3 (fr) |
| ES (1) | ES2116298T3 (fr) |
| GR (1) | GR3026519T3 (fr) |
| MX (1) | MX9101526A (fr) |
| WO (1) | WO1992006686A1 (fr) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5025035A (en) * | 1990-10-12 | 1991-06-18 | Warner-Lambert Company | Method of treating depression |
| US5510381A (en) * | 1995-05-15 | 1996-04-23 | Warner-Lambert Company | Method of treatment of mania and bipolar disorder |
| KR100512506B1 (ko) * | 1996-03-14 | 2005-12-21 | 워너-램버트 캄파니 엘엘씨 | 제약제제로서신규한치환시클릭아미노산 |
| US6372792B1 (en) | 1996-04-26 | 2002-04-16 | Guy Chouinard | Method for treating anxiety, anxiety disorders and insomnia |
| AU714980B2 (en) | 1996-07-24 | 2000-01-13 | Warner-Lambert Company Llc | Isobutylgaba and its derivatives for the treatment of pain |
| US6194459B1 (en) | 1997-08-19 | 2001-02-27 | Warner-Lambert Company | Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotors stimulants |
| WO1999018063A2 (fr) | 1997-10-07 | 1999-04-15 | Warner-Lambert Company | Procede de preparation d'un compose anticonvulsif, aminoacide et cyclique |
| HUP0004310A3 (en) * | 1997-10-27 | 2001-11-28 | Warner Lambert Co | Cyclic amino acids, and derivatives thereof and pharmaceutical compositions comprising the said compounds as active agents |
| BR9910494B1 (pt) * | 1998-05-15 | 2011-11-01 | composições sólidas contendo derivados de ácido gama-aminobutìrico e processo para o seu preparo. | |
| PL204921B1 (pl) | 1998-05-15 | 2010-02-26 | Warner Lambert Co | Stabilizowana kompozycja farmaceutyczna zawierająca 4-amino-3-podstawioną pochodną kwasu butanowego i α-aminokwas oraz sposób jej wytwarzania |
| US6992109B1 (en) * | 1999-04-08 | 2006-01-31 | Segal Catherine A | Method for the treatment of incontinence |
| CA2370030C (fr) * | 1999-04-09 | 2007-08-14 | Euro-Celtique S.A. | Composition de blocage du canal sodique et leur utilisation |
| HUP0200733A3 (en) * | 1999-04-09 | 2003-04-28 | Warner Lambert Co | Combinations of gaba analogs and tricyclic compounds to treat depression |
| AP2002002501A0 (en) * | 1999-10-07 | 2002-06-30 | Warner Lambert Co | Synergistic combinations of an NK1 receptor antagonist and a gaba structural analog. |
| WO2001097612A1 (fr) | 2000-06-16 | 2001-12-27 | Teva Pharmaceutical Industries Ltd. | Gabapentine stable contenant plus de 20 ppm d'ions chlore |
| JP4350508B2 (ja) | 2001-09-03 | 2009-10-21 | ニユーロン・フアーマシユーテイカルズ・エツセ・ピー・アー | ガバペンチンまたはその類似体とα−アミノアミドとを含む薬剤組成物およびその鎮痛用途 |
| ITMI20012750A1 (it) | 2001-12-21 | 2003-06-21 | Procos Spa | Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura |
| US20030119908A1 (en) * | 2001-12-21 | 2003-06-26 | Zambon Group S.P.A. | Stable gabapentin compositions |
| US20050181071A1 (en) * | 2004-02-18 | 2005-08-18 | Binder Michael R. | Method for the treatment of clinical depression |
| SI1809271T1 (sl) * | 2004-09-10 | 2010-10-29 | Newron Pharm Spa | Uporaba (R)-(halobenziloksi) benzilamino propanamidov kot selektivnih modulatorjev natrijevih in/ali kalcijevih kanalov |
| IN2012MN02923A (fr) | 2010-06-01 | 2015-06-05 | Rubicon Res Private Ltd | |
| WO2015144825A1 (fr) | 2014-03-27 | 2015-10-01 | Sanovel Ilac Sanayi Ve Ticaret A.S. | Solution pharmaceutique liquide orale de gabapentine |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US4087544A (en) * | 1974-12-21 | 1978-05-02 | Warner-Lambert Company | Treatment of cranial dysfunctions using novel cyclic amino acids |
| US5084479A (en) * | 1990-01-02 | 1992-01-28 | Warner-Lambert Company | Novel methods for treating neurodegenerative diseases |
| US5025035A (en) * | 1990-10-12 | 1991-06-18 | Warner-Lambert Company | Method of treating depression |
-
1990
- 1990-10-12 US US07/596,270 patent/US5025035A/en not_active Expired - Lifetime
-
1991
- 1991-10-02 DE DE69129115T patent/DE69129115T2/de not_active Expired - Fee Related
- 1991-10-02 JP JP51703391A patent/JP3192141B2/ja not_active Expired - Fee Related
- 1991-10-02 CA CA002092416A patent/CA2092416A1/fr not_active Abandoned
- 1991-10-02 AT AT91918381T patent/ATE164065T1/de not_active IP Right Cessation
- 1991-10-02 EP EP91918381A patent/EP0552240B1/fr not_active Expired - Lifetime
- 1991-10-02 WO PCT/US1991/007330 patent/WO1992006686A1/fr not_active Ceased
- 1991-10-02 ES ES91918381T patent/ES2116298T3/es not_active Expired - Lifetime
- 1991-10-02 DK DK91918381T patent/DK0552240T3/da active
- 1991-10-10 MX MX9101526A patent/MX9101526A/es unknown
-
1998
- 1998-04-03 GR GR980400703T patent/GR3026519T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE164065T1 (de) | 1998-04-15 |
| WO1992006686A1 (fr) | 1992-04-30 |
| GR3026519T3 (en) | 1998-07-31 |
| ES2116298T3 (es) | 1998-07-16 |
| CA2092416A1 (fr) | 1992-04-13 |
| JP3192141B2 (ja) | 2001-07-23 |
| MX9101526A (es) | 1992-06-05 |
| EP0552240B1 (fr) | 1998-03-18 |
| US5025035A (en) | 1991-06-18 |
| DE69129115D1 (de) | 1998-04-23 |
| EP0552240A4 (en) | 1993-09-01 |
| JPH06502148A (ja) | 1994-03-10 |
| DE69129115T2 (de) | 1998-07-16 |
| EP0552240A1 (fr) | 1993-07-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0552240T3 (da) | Ny metode til behandling af depression | |
| ATE33558T1 (de) | Stabilisierung von influenzavirusimpfstoffen. | |
| DK607689A (da) | Fremgangsmaade til behandling af laeder | |
| DK283881A (da) | Fremgangsmaade til fremstilling af pyrazinyl1,2,4-oxadiazol-5-oner | |
| ATE104269T1 (de) | Antidepressiva. | |
| ATE150319T1 (de) | Behandlung von asthma | |
| EA200000196A1 (ru) | Универсальная плазма крови | |
| DE59209129D1 (de) | Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression | |
| DK356785A (da) | Fremgangsmaade til inhibering af carbamylering ved behandling af peptider | |
| ATE111439T1 (de) | Verfahren zur herstellung von levodopa. | |
| DK0638068T3 (da) | Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner | |
| ATE204851T1 (de) | Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten | |
| ES539382A0 (es) | Procedimiento para la determinacion de fibrina | |
| DE69131657D1 (de) | Verfahren zur industriellen Herstellung von 4-Chloro-3-sulfamoyl-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)-Benzamid | |
| DK0743060T3 (da) | Anvendelse af tandplejemidler indeholdende bovint colostrum | |
| DK0996435T3 (da) | Aminosyrederivater anvendelige til behandling af slagtilfælde | |
| DK0744027T3 (da) | Anvendelse af fremgangsmåder til identifikation af hydrofile signaloligopeptider | |
| DE68912809D1 (de) | Verfahren zur Herstellung von Bis(2,2,6,6-tetramethyl-4-piperidyl)amin. | |
| DE68903208D1 (de) | Verfahren zur thermischen behandlung von laktoferrin. | |
| DK192890D0 (da) | 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme | |
| DK0673441T3 (da) | Fremgangsmåde til kasein-overfladebehandling af læder | |
| DE3787954D1 (de) | Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen. | |
| DK661388A (da) | Fremgangsmaade til fremstilling af thiophenforbindelser | |
| ATE82124T1 (de) | Anwendung von n-(2-(diaethylamino)aethyl>-2-methoxy-4((1-h-4,5ihydro-2-imidazolyl)amino>-5- chlorobenzamid als anxiolytisches und antipsychotisches mittel. | |
| DK0779297T3 (da) | Antigene peptider med glycinsubstitutioner |